Navigation Links
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
Date:8/1/2009

Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its Inclinicalperform application. Inclinicalperform is software-as-a-subscription (SaaS) based collaboration Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical research community to reduce both costs and effort in tracking, monitoring and aggregating information that is created during the clinical trials process.

Thousand Oaks, CA (PRWEB) August 1, 2009 -- Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its inclinicalperform application. Inclinicalperform is software-as-a-subscription (SaaS) based collaboration Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical research community to reduce both costs and effort in tracking, monitoring and aggregating information that is created during the clinical trials process.

With this agreement, Terrosa will have exclusive responsibility to for the sales and marketing of Integrated Clinical Solutions' Inclinicalperform Terrosa Technologies, LLC will develop the go-to-market strategies as well operations for sales, marketing and support for inclinicalperform This partnership expands on Terrosa's successful SaaS software conversion services and will speed time to market for independent software vendors (ISVs) such as Integrated Clinical Solutions. "We are pleased to partner with Integrated Clinical Solutions so that they may maintain their focus on further development and roadmap to incorporating new process automations within inclinicalperform" said Kim Terry, President of Terrosa Technologies.

inclinicalperform's collaboration software platform will benefit the clinical research community by taking much of the manual work out of tracking, monitoring and aggregating information that is created during the clinical trials process. "Our software makes the clinical operations job easier by providing a consistent collaborative work process that is straightforward and self documenting", said Inclinical's founder J. Peter Armerding, "Terrosa's integrated services will allow us to do what we do best - Clinical Operations Process Automation".

Terrosa Technologies (www.terrosatech.com) specializes in the migration of on premise applications into subscription based services to drive down costs and make high quality software more available to companies of all sizes. "Response for this type of comprehensive service has been tremendous because of the Return on Investment and Total Cost of Ownership benefits," states Terrosa President, Kim Terry. "We work with software companies who have domain expertise, turning them into SaaS providers with a powerful marketing and sales program."

About Terrosa Technologies:

Terrosa technology is an early innovator in working with software developers who need assistance to take their application to the SaaS environment and in providing go-to-market planning and Sales and Marketing operations. In addition, Terrosa Technologies also achieves positive results for our customers in transition in-house systems to Software as a Service delivered systems, Platform as a Service, or other technologies collectively known as Cloud Computing. Enormous efficiencies are expected to quickly drive down the cost of application programs for everyone using this technology.

About Integrated Clinical Solutions:

Integrated Clinical Solutions, Inc. (www.inclinical.com) creates software exclusively for clinical trial operations organizations. We bring process automation to clinical operations in the pharmaceutical, biotechnology and medical device industries. After encountering all the difficulties of implementing other leading clinical software programs, we realized that the cost of implementation and lost time for stakeholders to learn new programs was a large hurdle to overcome when you bring new systems online. We designed our software to be implemented quickly and easily understood by clinical operations end users.

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2702264.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
2. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
3. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
4. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
5. DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
6. 4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
7. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
8. Supelco(R) and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water
9. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
10. Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
11. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):